Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

NCT05475106 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Instituto de Medicina Regenerativa